a procedureGastric balloon

A soft balloon is placed in the stomach and filled, so the stomach holds less and fullness comes sooner. It is a temporary device, not an operation: nothing is cut, stapled or removed, and it comes out again. In the NHS description a camera goes down first, then the empty balloon is swallowed with a thin tube attached that fills it with salt water once in place; the whole thing takes around 20 minutes. The FDA states the maximum placement period for the two liquid-filled brands it wrote to providers about as six months.

The balloon is the cheapest line on a bariatric price column and the one most likely to be misread as the cheap version of the operations above it. On a Tijuana page it sits at 1,880 US dollars, a sleeve at 4,580 and a bypass at 5,980. It is not a cheaper sleeve. It is a rental.

The price paid is therefore for months, and the comparison that matters is not against an operation but against the same months without a device. Inference — a package whose purchase and removal happen in different countries has a problem the operations do not: the removal is a second appointment, months later, and the price that covered the insertion was paid to a clinic on another continent. A US clinic page read for this record prices the balloon with removal folded in, and names early removal for intolerance among the things the price does not cover — the single commonest reason a balloon comes out ahead of schedule.

The regulator has written to clinicians about this device twice. The FDA's letter of 9 February 2017, updated in August 2017 and April 2020, concerns the liquid-filled Orbera and ReShape systems and names two problems: spontaneous hyperinflation of the balloon, reported as early as nine days after placement, and acute pancreatitis developing within three days of it. The letter asks providers to keep both in mind when a patient presents with severe abdominal pain, distension or difficulty breathing.

Trade practice — balloons are sold alongside operations by clinics whose surgical packages need a lower entry price, and to patients whose weight is below the thresholds a surgical programme would accept.

Placed endoscopically under sedation, or swallowed as a capsule in the newer designs, as a day case with no ward stay. The removal is the part that determines where it can sensibly be bought: a retrieved balloon needs a second endoscopy at the end of its placement period, while a self-dissolving design passes on its own — one US page read for this record puts that type's life at about four months. A device bought abroad and retrieved at home is two providers and one shared responsibility.

The published prices split the same way. The US page prices Orbera at 6,000 to 8,500 dollars and Allurion at 6,000 to 9,000, stating that the price covers the device, the insertion, anaesthesia, facility costs, removal at six months, the pre-procedure consultation, follow-up visits and nutritionist support — and that it does not cover pre-procedure medical clearance, anti-nausea medication, treatment of complications, early removal if the patient cannot tolerate it, post-removal support, or food and supplements. A Tijuana page prices the same category of device at 1,880 dollars without publishing an inclusion list at all.

No national regulator read for this record publishes outcome figures for this device. The FDA's published material on it is about adverse events, not effectiveness.

As of September 2026 the published prices read off pages for this record are from 1,880 US dollars in Tijuana and 6,000 to 9,000 US dollars in the United States, with the FDA's six-month maximum placement period unchanged for the liquid-filled brands it named. A price is for a device that will be removed, and any page that lists it beside permanent operations is listing two different kinds of thing in one column.

This page describes a temporary device and reports what its regulator and published price pages say about it. It is not medical advice.